A Simple, Rapid and Sensitive UFLC-MS/MS Method for the Quantification of Oral Contraceptive Norgestrel in Human Plasma and its Pharmacokinetic Applications

Abstract

A simple, rapid and sensitive ultra flow liquid chromatography-tandem mass spectrometry (UFLC-MS/MS) assay for the determination of norgestrel in human plasma was developed using levonorgestrel D₆ as an internal standard (IS). Norgestrel and IS were extracted from human plasma via liquid-liquid extraction. Chromatographic separation was achieved on a Zorbax XDB-Phenyl column under isocratic conditions. Detection was done by tandem mass spectrometry, operating in positive ion mode. The protonated precursor to product ion transitions monitored for norgestrel and IS were at m/z 313.30→245.40 and 319.00→251.30 respectively. The method was fully validated as per current regulatory guidelines. Anticoagulant counter ion effect was also assessed with K₂EDTA and K₃EDTA. The method was validated with a linearity range of 304.356–50 807.337 pg/mL having run time of 2.0 min per sample. The method has shown tremendous reproducibility with intra- and inter-day precision (%CV) less than 11.0% and intra- and inter-day accuracy less than 9.0% of nominal values. The validated method was applied to a pharmacokinetic study in human plasma samples generated after administrating a single oral dose of 0.3 mg norgestrel tablets to healthy female volunteers and has proved to be highly reliable for the analysis of clinical samples.

Key words

norgestrel - oral contraceptive - UFLC-MS/MS - method validation - pharmacokinetics

• References

• 1 Uniyal JP, Buckshee K, Bhargava VL et al. Binding of norgestrel to receptor proteins in the human endometrium and myometrium. Journal of Steroid Biochemistry 1977; 8: 1183-1188
• 2 Santillan R, Palacios GP, Reyes M et al. Assessment of the oestrogenic activity of the contraceptive progestin levonorgestrel and its non-phenolic metabolites. European Journal of Pharmacology 2001; 427: 167-174
• 3 Jones RL, Critchley HOD. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery. Human Reproduction 2000; 15: 162-172
• 4 Munuce MJ, Nascimento JA, Rosano G et al. Doses of levonorgestrel comparable to that delivered by the levonorgestrel-releasing intrauterine system can modify the in vitro expression of zona binding sites of human spermatozoa. Contraception 2005; 73: 97-101
• 5 Rowlands S, Kubba AA, Guillebaud J et al. A possible mechanism of action of danazol and an ethinylestradiol/norgestrel combination used as postcoital contraceptive agents. Journal of Contraception 1986; 33: 539-545
• 6 Ling WY, Wrixon W, Jayid I et al. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium. Fertility and Sterility 1983; 39: 292-297
• 7 Guengerich FP. Role of cytochrome P450 enzymes in drug-drug interactions. Advances in Pharmacology 1997; 43: 7-35
• 8 Veronese ML, Gillen LP, Burke JP et al. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. Journal of Clinical Pharmacology 2003; 43: 831-839
• 9 Catherine M, John K. Development of a Validated Liquid Chromatography Method for the Simultaneous Determination of Ethinyl Estradiol, Cyproterone Acetate and Norgestrel in Breast Milk Following Solid-Phase Extraction. Journal of Liquid Chromatography & Related Technologies 2006; 29: 685-700
• 10 Gorog S, Bihari M, Csizer E et al. Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices. Journal of Pharmaceutical and Biomedical Analysis 1995; 14: 85-92
• 11 Tetsuo M, Axelson M, Sjovall J. Selective isolation procedures for GC/MS analysis of ethynyl steroids in biological material. Journal of Steroid Biochemistry 1980; 13: 847-860
• 12 Warren RJ, Fotherby K. Radioimmunoassay of synthetic Progestogens, Norethisterone and Norgestrel. Journal of Endocrinology 1974; 62: 605-618
• 13 Brunis AP. Atmospheric-pressure-ionization mass spectrometry: I. Instrumentation and ionization techniques. Trends in Analytical Chemistry 1994; 13: 81-90
• 14 Muck W. Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Pharmazie 1999; 54: 639-644
• 15 Wu Z, Zhang C, Yang C et al. Simultaneous quantitative determination of norgestrel and progesterone in human serum by high-performance liquid chromatography-tandem mass spectrometry with atmospheric pressure chemical ionization. Analyst 2000; 125: 2201-2205
• 16 Sapozhnikova Y, Hedgespeth M, Wirth E et al. Analysis of selected natural and synthetic hormones by LC-MS-MS using the US EPA method 1694. Analytical Methods 2011; 3: 1079-1086
• 17 Guidance for Industry . Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Rockville, MD: 2001. Available from: http://www.fda.gov/CVM
• 18 Viswanathan CT, Bansal S, Booth B et al. Workshop/conference report – quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS Journal 2007; 9: E30-E42